Investor relations

We use the innovative power in combining material science and pharma,
revolutionizing drug delivery and giving patients a better and safer everyday life

We create new and innovative products with shorter time to market and mitigated risk.
We make this possible by combining material science & pharmaceutical development and by using established and approved active substances.

Press Releases

All
Regulatory
2021-11-25
Regulatory
EMPLICURE IS RECRUITING NEW CFO
2021-11-23
EMPLICURE PRESENTS ON STORA AKTIEDAGEN DECEMBER 2
2021-11-19
Regulatory
EMPLICURE INTERIM REPORT JANUARY-SEPTEMBER 2021 - BUILDING A STRONG TEAM AND A FOUNDATION FOR GROWTH

Latest Reports

2021-11-19
EMPLICURE DELÅRSRAPPORT Q3 2021 - VI BYGGER ETT STARKT TEAM OCH LÄGGER GRUNDEN FOR TILLVÄXT

Financial Calendar

December 02 2021
Stora Aktiedagen

CEO Torbjörn W. Larsson presents the company on Aktiespararnas event Stora Aktiedagen in Stockholm.
Follow the presentation live online, via www.aktiespararna.se/tv/live.

February 22 2022
Year-end Report 2021

IR contact

Torbjörn W. Larsson CEO
+46 (0)70-747 65 99 torbjorn.walkerlarsson@emplicure.com

Subscribe

Recieve press releases and reports via email.